Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as 1st-line Chemotherapy in Patients With Metastatic Esophageal Cancer.

NCT00209690 is registered in ClinicalTrials.gov with Hokkaido Gastrointestinal Cancer Study Group as lead sponsor.

NCT NCT00209690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as 1st-line Chemotherapy in Patients With Metastatic Esophageal Cancer.
Lead sponsor
Hokkaido Gastrointestinal Cancer Study Group
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2003
Completion date
April 30, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer